Neuro-Oncology Reviews
Volume
24 Number 2
31 January 2022
Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 2, 31 January
*
Latif
G, Yousif Al Anezi F, Iskandar DNFA, Bashar A, Alghazo J.
Recent
Advances
in Classification of Brain Tumor from MR Images - State of the Art
Review
from 2017 to 2021.
Curr
Med Imaging. 2022 Jan 17;18(9):903-918→.
doi: 10.2174/1573405618666220117151726→.
PMID: 35040408→.
Review˰ ˍ
Rathi
S, Griffith JI, Zhang W, Zhang W, Oh JH, Talele S, Sarkaria JN,
Elmquist WF.
The
influence of the blood-brain barrier in the treatment of brain
tumours.
J
Intern Med. 2022 Jan 17;292(1):3-30→.
doi: 10.1111/joim.13440→.
PMID: 35040235→.
Review˰ ˍ
Sabahi
M, Bordes SJ, Najera E, Mohammadi AM, Barnett GH, Adada B,
Borghei-Razavi H.
Laser
Interstitial Thermal Therapy for Posterior Fossa Lesions: A
Systematic
Review and Analysis of Multi-Institutional Outcomes.
Cancers
(Basel). 2022 Jan 17;14(2):456→.
doi: 10.3390/cancers14020456→.
PMID: 35053618→.
Review. ˍ
Seker-Polat
F, Pinarbasi Degirmenci N, Solaroglu I, Bagci-Onder T.
Tumor
Cell
Infiltration
into the Brain in Glioblastoma: From Mechanisms to Clinical
Perspectives.
Cancers
(Basel). 2022 Jan 17;14(2):443→.
doi: 10.3390/cancers14020443→.
PMID: 35053605→.
Review. ˍ
Truong
MT, et al., PDQ Adult Treatment Editorial Board.
Adult
Central Nervous System Tumors
Treatment
(PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ. 2022 Jan 18→.
NCBI Bookshelf ID: NBK65982→.
PMID: 26389419→.
Review. ˍ
Abdoli
Shadbad M, Hemmat N, Khaze Shahgoli V, Derakhshani A, Baradaran F,
Brunetti O, Fasano R, Bernardini R, Silvestris N, Baradaran B.
A
Systematic
Review
on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma
Therapy: From
Deciphering to Personalized Medicine.
Front
Immunol. 2022 Jan 19, 2021;12:788211→.
doi: 10.3389/fimmu.2021.788211→.
PMID: 35126356→.
Review. ˍ
Zhao
T, Li C, Ge H, Lin Y, Kang D.
Glioblastoma
vaccine tumor therapy
research
progress.
Chin
Neurosurg J. 2022 Jan 19;8(1):2→.
doi: 10.1186/s41016-021-00269-7→.
PMID: 35045874→.
Review. ˍ
Chen
Z, Huang Y, Cao D, Qiu S, Chen B, Li J, Bao Y, Wei Q, Han P, Liu
L.
Vitamin
C Intake and Cancers: An Umbrella Review.
Front
Nutr. 2022 Jan 20, 2021;8:812394→.
doi: 10.3389/fnut.2021.812394→.
PMID: 35127793→.
Review. ˍ
Hwang
EI, Sayour EJ, Flores CT, Grant G, Wechsler-Reya R, Hoang-Minh LB,
Kieran MW, Salcido J, Prins RM, Figg JW, Platten M, Candelario KM,
Hale PG, Blatt JE, Governale LS, Okada H, Mitchell DA, Pollack
IF.
The
current landscape
of
immunotherapy for pediatric brain tumors.
Nat
Cancer. 2022 Jan 20;3(1):11-24→.
doi: 10.1038/s43018-021-00319-0→.
PMID: 35121998→.
Review˰ ˍ
Kurokawa
R, Baba A, Kurokawa M, Capizzano A, Hassan O, Johnson T, Ota Y,
Kim J, Hagiwara A, Moritani T, Srinivasan A.
Pretreatment
ADC Histogram Analysis as
a
Prognostic Imaging Biomarker for Patients with Recurrent
Glioblastoma Treated
with
Bevacizumab: A Systematic Review and Meta-analysis.
AJNR
Am J Neuroradiol. 2022 Jan 20;43(2):202-206→.
doi: 10.3174/ajnr.A7406→.
PMID: 35058300→.
Review, Meta-analysis˰ ˍ
Sanati
M, Aminyavari S, Mollazadeh H, Bibak B, Mohtashami E, Afshari
AR.
How
do
phosphodiesterase-5 inhibitors affect cancer? A focus on
glioblastoma
multiforme.
Pharmacol
Rep. 2022 Jan 20;74(2):323-339→.
doi: 10.1007/s43440-021-00349-6→.
PMID: 35050491→.
Review˰ ˍ
Bhargav
AG, Domino JS, Chamoun R, Thomas SM.
Mechanical
Properties in the
Glioma
Microenvironment: Emerging Insights and Theranostic
Opportunities.
Front
Oncol. 2022 Jan 21, 2021;11:805628→.
doi: 10.3389/fonc.2021.805628→.
PMID: 35127517→.
Review. ˍ
Russo
C, Scala MR, Spennato P, Nastro A, Errico ME, De Martino L,
Cinalli G.
Primary
leptomeningeal medulloblastoma: a case-based review.
Childs
Nerv Syst. 2022 Jan 21;38(3):527-536→.
doi: 10.1007/s00381-021-05435-x→.
PMID: 35059784→.
Review˰ ˍ
Quader
S, Kataoka K, Cabral H.
Nanomedicine
for brain cancer.
Adv
Drug Deliv Rev. 2022 Jan 22;182:114115→.
doi: 10.1016/j.addr.2022.114115→.
PMID: 35077821→.
Review˰ ˍ
Yamasaki
F.
Adolescent
and young adult brain tumors: current topics and
review.
Int
J Clin Oncol. 2022 Jan 22;27(3):457-464→.
doi: 10.1007/s10147-021-02084-7→.
PMID: 35064353→.
Review. ˍ
Li
Y, Sharma A, Maciaczyk J, Schmidt-Wolf IGH.
Recent
Development in NKT-Based Immunotherapy of Glioblastoma: From Bench
to Bedside.
Int
J Mol Sci. 2022 Jan 24;23(3):1311→.
doi: 10.3390/ijms23031311→.
PMID: 35163235→.
Review. ˍ
Bausart
M, Préat V, Malfanti A.
Immunotherapy
for glioblastoma: the promise
of
combination strategies.
J
Exp Clin Cancer Res. 2022 Jan 25;41(1):35→.
doi: 10.1186/s13046-022-02251-2→.
PMID: 35078492→.
Review. ˍ
Shamshiripour
P, Nikoobakht M, Mansourinejad Z, Ahmadvand D, Akbarpour M.
A
comprehensive
update to DC therapy for glioma; a systematic review and
meta-analysis.
Expert
Rev Vaccines. 2022 Jan 25;21(4):513-531→.
doi: 10.1080/14760584.2022.2027759→.
PMID: 35076331→.
Review, Meta-analysis˰ ˍ
Lehrer
EJ, Ruiz-Garcia H, Nehlsen AD, Sindhu KK, Estrada RS, Borst GR,
Sheehan JP, Quinones-Hinojosa A, Trifiletti DM.
Preoperative
Stereotactic
Radiosurgery
for Glioblastoma.
Biology
(Basel). 2022 Jan 26;11(2):194→.
doi: 10.3390/biology11020194→.
PMID: 35205059→.
Review. ˍ
Sidibe
I, Tensaouti F, Roques M, Cohen-Jonathan-Moyal E, Laprie
A.
Pseudoprogression
in Glioblastoma: Role of Metabolic and Functional MRI
-
Systematic
Review.
Biomedicines.
2022 Jan 26;10(2):285→.
doi: 10.3390/biomedicines10020285→.
PMID: 35203493→.
Review. ˍ
Amarandi
RM, Ibanescu A, Carasevici E, Marin L, Dragoi B.
Liposomal-Based
Formulations:
A Path from Basic Research to Temozolomide Delivery Inside
Glioblastoma
Tissue.
Pharmaceutics.
2022 Jan 27;14(2):308→.
doi: 10.3390/pharmaceutics14020308→.
PMID: 35214041→.
Review.
ˍ
Burns
I, Gwynne WD, Suk Y, Custers S, Chaudhry I, Venugopal C, Singh
SK.
The
Road
to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and
New
Avenues.
Front
Oncol. 2022 Jan 27;12:815726→.
doi: 10.3389/fonc.2022.815726→.
PMID: 35155252→.
Review. ˍ
Ghasemi
DR, Fleischhack G, Milde T, Pajtler KW.
The
Current Landscape of
Targeted
Clinical Trials in Non-WNT/Non-SHH Medulloblastoma.
Cancers
(Basel). 2022 Jan 28;14(3):679→.
doi: 10.3390/cancers14030679→.
PMID: 35158947→.
Review.
ˍ
Han
MH, Kim CH.
Current
Immunotherapeutic Approaches for Malignant Gliomas.
Brain
Tumor Res Treat. 2022 Jan 28;10(1):1-11→.
doi: 10.14791/btrt.2022.10.e25→.
PMID: 35118842→.
Review. ˍ
Li
J, Meng Q, Xuehui Zhou, Zhao H, Wang K, Niu H, Wang Y.
Gospel
of malignant
Glioma:
Oncolytic virus therapy.
Gene.
2022 Jan 28;818:146217→.
doi: 10.1016/j.gene.2022.146217→.
PMID: 35093451→.
Review˰ ˍ
Wee
CW.
Radiotherapy
for Newly Diagnosed Glioblastoma in the Elderly: What Is
the
Standard?
Brain
Tumor Res Treat. 2022 Jan 28;10(1):12-21→.
doi: 10.14791/btrt.2022.10.e34→.
PMID: 35118843→.
Review. ˍ